共 26 条
[1]
Amant F., Moerman P., Neven P., Timmerman D., van Limbergen E., Vergote I., Endometrial cancer, Lancet, 366, pp. 491-505, (2005)
[2]
Parkin D.M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002, CA Cancer J Clin, 55, pp. 74-108, (2005)
[3]
Rose P.G., Endometrial carcinoma, N Engl J Med, 335, pp. 640-649, (1996)
[4]
Trope C.G., Alektiar K.M., Sabbatini P.J., Et al., Corpus: epithelial tumors, In: Principles and practice of gynecologic oncology, (2005)
[5]
Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., Heller P.B., Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study, Cancer, 60, pp. 2035-2041, (1987)
[6]
Wong R.J., Lin D.T., Schoder H., Patel S.G., Gonen M., Wolden S., Et al., Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma, J Clin Oncol, 20, pp. 4199-4208, (2002)
[7]
Minn H., Lapela M., Klemi P.J., Grenman R., Leskinen S., Lindholm P., Et al., Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer, J Nucl Med, 38, pp. 1907-1911, (1997)
[8]
Allal A.S., Dulguerov P., Allaoua M., Haenggeli C.A., el El-Ghazi A., Lehmann W., Et al., Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy, J Clin Oncol, 20, pp. 1398-1404, (2002)
[9]
Casasnovas R.O., Meignan M., Berriolo-Riedinger A., Bardet S., Julian A., Thieblemont C., Et al., SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma, Blood, 118, pp. 37-43, (2011)
[10]
Itti E., Lin C., Dupuis J., Paone G., Capacchione D., Rahmouni A., Et al., Prognostic value of interim 18F-FDG PET in patients with diffuse large B-cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy, J Nucl Med, 50, pp. 527-533, (2009)